Medicare Plan Finder: How to Start with Coverage You Need

Changes to Medicare Plan Finder in 2026

Trump’s drug pricing push sidelines Medicare negotiation program

Rather than strengthening Medicare negotiation, bills have passed to further exempt or delay negotiation for even more drugs approved for rare diseases. For example, price negotiations for Jakafi, approved for rare bone marrow cancer and other non-rare blood conditions, are delayed until 2028. Dr. Ramachandran lays out the situation and refutes pharma’s argument highlighting that the CBO predicts these new exemptions and delays will cost Medicare, and thus taxpayers, up to $8.8 billion over the

A step-by-step guide to signing up for Medicare online